Engineering and biofabrication of early cancer models
文章探讨了早期癌症模型的工程与生物制造，强调了早期检测的重要性及其对改善癌症治疗结果的潜力。通过组织工程和生物制造技术，如生物打印和器官芯片，研究人员能够更好地理解早期癌症生物学，并开发新的生物标志物。文章还提到，人工智能和机器学习的结合将进一步推动早期癌症检测和个性化干预的发展。
Metabolic reprogramming in ischemic stroke: when glycolytic overdrive meets lipid storm
The article delves into metabolic reprogramming in ischemic stroke, proposing that the interplay between glycolytic overdrive and lipid metabolism is crucial for neuronal survival and recovery. It discusses innovative therapeutic strategies that could transform stroke management, emphasizing the need for precision in targeting metabolic pathways. By framing stroke as a systemic metabolic disorder rather than merely a vascular event, the research opens avenues for novel interventions that could significantly improve patient outcomes.
A modular high-throughput approach for advancing synthetic biology in the chloroplast of Chlamydomonas
本研究通过建立一个高通量平台，推进了绿藻Chlamydomonas reinhardtii的叶绿体合成生物学，显著增强了基因工程能力。研究提供了一套基础的遗传元件，适用于叶绿体的工程化，具有潜在的农业和生物技术应用，尤其是在提高作物抗逆性和产量方面。
Engineered elicitation in Artemisia annua L. callus cultures alters artemisinin biosynthesis, antioxidant responses, and bioactivity
This study investigates the effects of engineered elicitation on artemisinin biosynthesis in callus cultures of Artemisia annua, focusing on the role of plant growth regulators and silver nitrate. The findings indicate that specific combinations of elicitors can enhance the production of artemisinin, a critical compound for malaria treatment. The research highlights the potential for biotechnological applications in sustainable pharmaceutical production, addressing the challenges of low yields in natural conditions.
Sino-C, a novel sinomenine derivative, induces cell death by disrupting cholesterol homeostasis in colorectal cancer cells
Sino-C是一种新合成的中药衍生物，针对结肠癌细胞表现出显著的抗癌活性。研究表明，Sino-C通过调节胆固醇代谢诱导细胞死亡，并与患者的生存结果相关联。这一发现突显了Sino-C在结肠癌治疗中的潜在应用价值，尤其是在早期研发阶段，具有良好的商业前景。
A novel drug series optimized to address cystic fibrosis and other CFTR deficiency diseases of human airways
研究开发了一系列新型药物，旨在激活囊性纤维化转膜导管调节因子（CFTR），以治疗囊性纤维化及其他CFTR缺陷相关疾病。新化合物通过抑制磷酸二酯酶，增强CFTR功能，展现出显著的临床应用潜力，尤其是在现有治疗无效的患者中。这些药物的研发不仅有助于改善囊性纤维化患者的生活质量，也可能对其他呼吸道疾病产生积极影响。
MS1-96 induces HIP1R-dependent PD-L1 degradation and promotes antitumor immunity in colorectal cancer
MS1-96是一种新型小分子药物，能够通过HIP1R介导的机制降解PD-L1，从而增强结直肠癌的抗肿瘤免疫。研究表明，MS1-96在多种结直肠癌细胞系中有效降低PD-L1蛋白水平，并在小鼠模型中显示出显著的抗肿瘤效果。这一发现为癌症免疫治疗提供了新的策略，具有重要的临床应用潜力。
A cross sectional feasibility study to evaluate the usability and efficacy of Swaasa AI platform for rapid respiratory health assessment
Swaasa AI平台通过分析咳嗽声实现快速呼吸健康评估，显示出高敏感性（97.27%）和准确性（87.32%），为呼吸疾病的早期筛查提供了有效工具。该平台在印度的研究强调了在资源有限地区应用AI技术的必要性，具有广泛的市场潜力和商业价值。
Microglia-derived nanovesicles synchronize macroautophagy and chaperone-mediated autophagy for Alzheimer’s disease therapy
AR@ENV, a microglia-derived nanovesicle engineered via the MiLi-FE process, synchronizes macroautophagy and chaperone-mediated autophagy for Alzheimer's disease therapy. This innovative approach effectively crosses the blood-brain barrier, targets inflammatory sites, and enhances the clearance of neurotoxic aggregates. In preclinical models, AR@ENV significantly improves cognitive function and reduces neuroinflammation, showcasing its potential as a promising therapeutic strategy for neurodegenerative disorders.
Combining real-time AI and in-person expert instruction in simulated surgical skills training - Randomized crossover trial
本研究探讨了实时AI与人类专家结合的外科技能培训方法，结果显示AI反馈显著提高了学员的表现，尤其在技能转移方面。研究在加拿大的多所医学院进行，涉及多名医学专业学生，强调了AI与人类专家反馈的互补优势，具有显著的学习效果和潜在的商业应用价值。
Enhanced stratification of male pattern hair loss using AI through novel loss region ratio analysis
该研究提出了一种基于AI的男性型脱发（MPHL）分级框架，利用新颖的区域比率分析方法，显著提高了MPHL的诊断准确性和客观性。通过分析257名患者的761张图像，AI模型在分级中表现出高达97.6%的精度，尤其在高级别分级中表现优异。该方法的创新性在于结合了深度学习技术与定量分析，为临床提供了更可靠的工具，具有广泛的应用潜力。
EHBMT, a method for visualizing tumor evolution, identifies a surge in gastric cancer with hybrid epithelial–mesenchymal phenotypes due to an inflammatory microenvironment
本研究提出了一种基于上皮-间质转化（EMT）异质性的分子分型方法（EHBMT），用于可视化胃癌的演变过程。研究发现，胃癌中混合上皮-间质表型的比例显著增加，与炎症微环境密切相关。该方法为个性化医学提供了新的指导思路，可能对胃癌的诊断和治疗产生重要影响。
STAT+: Caribou’s off-the-shelf CAR-T therapy shows promise in lymphoma study
Caribou Biosciences的CAR-T疗法vispa-cel在淋巴瘤患者中显示出显著的临床效果，64%的患者实现完全缓解，82%的整体反应率。研究结果表明，该疗法在疗效上与现有的患者特异性CAR-T疗法相当，可能推动这一领域的发展并扩大细胞治疗的可及性。
Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial
The CASTLE-01 trial evaluated the efficacy of cryoablation combined with sintilimab and lenvatinib in patients with advanced intrahepatic cholangiocarcinoma (ICC). The study found a 75% objective response rate, with median progression-free survival of 16.8 months and overall survival of 25.4 months. The combination therapy was well tolerated and showed potential to enhance systemic antitumor immunity, suggesting a new treatment paradigm for ICC. These findings highlight the importance of innovative approaches in addressing the rising incidence of ICC globally.
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies
研究针对CLDN18.2靶向免疫疗法在胃癌治疗中的毒性问题进行了深入探讨，发现该疗法在临床应用中可能导致严重的胃部不良反应。为了解决这一问题，研究团队开发了新的CAR T细胞策略，旨在降低毒性并保持抗肿瘤效力。该研究的结果为CLDN18.2靶向治疗提供了新的思路，具有重要的临床和商业潜力。